RxDoctor Payments Data

Mark Borigini

Rheumatology · Downey, CANPI 1043257082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $919,548 of the $919,548 with a category attached, or 100.0%. Otsuka Pharmaceutical Co., Ltd. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2023 is the largest year on record at $347,780, more than ten times the $300 reported in 2019. Among rheumatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$919,548in general payments, 2019–2025

Across 79 payments — averaging $11,640 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Co., Ltd.$919K
  • GSK$300

What the payments were for

  • Consulting fees$919,548100%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka Pharmaceutical Co., Ltd.78$919,248
GSK1$300

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$919,548 in reported general payments places this provider in the 95th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California

Other rheumatology in Downey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →